LNRR students among the top young researchers awarded at the 25th Iranian and 4th International Congress of Physiology and Pharmacology
Atefeh Rayatpour, Ph.D candidate in Medical Physiology won the Nasser Giti Award at the 25th Iranian and 4th International Congress of Physiology and Pharmacology.
Prof. Nasser Giti (1914-2005), was one of the prominent professors in Iran and one of the founding members of the Iranian Society of Physiology and Pharmacology. An award attributed to Dr. Giti is given to young researchers in the field of physiology and pharmacology at every congress of the society. This award is the congress’s most prestigious prize for young researchers.
Atefeh Rayatpour presented an oral poster entitled “Deferiprone Decreases Demyelination in Mice with Demyelinated Optic Nerve”. This study was performed in the Laboratory for Neural Regeneration and Repair under the supervision of Dr. Mohammad Javan.
In this study, which was performed with the aim of reducing iron deposition in the mouse demyelinated optic nerve, the presence of iron deposits and anti-inflammatory and protective effects of DFP were investigated.
The 25th Iranian and 4th International Congress of Physiology and Pharmacology was held online on October 20-22, 2021 by Tehran University of Medical Sciences and the Iranian Society of Physiology and Pharmacology.
Ms. Melika Tavakoli, MSc student in medical physiology, won the labsnet grant in the 25th Iranian and 4th International Congress of Physiology and Pharmacology. She presented an oral poster entitles “Investigating the effect of HDACs inhibition on the inflammation level and myelin repair process in an experimental model of multiple sclerosis”.
In this study, which is done in LNRR, Ms. Tavakoli has shown that inhibition of histone deacetylase enzymes could enhance progenitor cells differentiation in long lasting animal model of demyelination, which leads to effective myelin repair, and reduction of inflammation. Inactivation of progenitor cells in multiple sclerosis is one of the main reasons for the progression of the disease toward permanent disability.
